Kymera Therapeutics, Inc. <KYMR.O>: Stifel Raises Target Price to $152 From $132
KYMR•Related News
Mgic Investment Corporation <MTG.N>: BTIG Assumes Coverage With Neutral Rating
MTG•
JPMorgan Chase crosses 10% stake threshold in Ubisoft, holds 10.06% of capital
JPM•
Cypherpunk Technologies appoints Nakamoto COO Amanda Fabiano to board
CYPH•
Zenas Biopharma Announces Upcoming Presentations Of Obexelimab Data In IgG4-Related Disease At The IgG4WARD! 6th International Symposium On IgG4-Related Disease And ACR Convergence 2026
ZBIO•
Twilio Inc. <TWLO.N>: Rosenblatt Securities Raises Target Price to $290 From $275
TWLO•